-
Tuesday's Top Gainers on NASDAQ: FairPoint, MAKO Surgical, Luminex, Syntroleum
Wednesday, August 10, 2011 - 11:16am | 542POINT ROBERTS - August 10, 2011 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for Aug. 08, 2011. FairPoint Communications was the notable winner in yesterday's sessions with the stock gaining 44.32%. FairPoint...
-
BIOLASE Announces Stock Repurchase Program of up to 2M Shares
Wednesday, August 10, 2011 - 8:46am | 44BIOLASE Technology, Inc. (NASDAQ: BLTI), the World's leading dental laser manufacturer and distributor, today announced that its Board of Directors has approved a stock repurchase program of up to 2,000,000 shares of the Company's outstanding common stock.
-
BIOLASE Fulfills All Prepaid Purchase Orders Under Henry Schein Agreement
Wednesday, August 10, 2011 - 8:32am | 98BIOLASE Technology, Inc. (NASDAQ: BLTI) today announced that it has fulfilled the second of two prepaid purchase orders totaling approximately $9 million under the Distribution and Supply Agreement entered into with Henry Schein (NASDAQ: HSIC) on September 23, 2010. The final products required to...
-
UPDATE: Piper Jaffray Lowering Price Target On Masimo
Wednesday, August 10, 2011 - 8:09am | 141Piper Jaffray is out with a research report on Masimo Corporation (NASDAQ: MASI) and is lowering its price target to $36 from $38, but is keeping its Overweight rating on shares. In a note to clients, Piper Jaffray writes, "Masimo reported mixed 2Q11 results, with overall revenue missing our and...
-
UPDATE: Morgan Keegan Reiterates Outperform on Masimo, Slashes PT to $33
Wednesday, August 10, 2011 - 7:37am | 47Morgan Keegan reiterated its Outperform rating on Masimo (NASDAQ: MASI). At the same time, the rating agency reduced its price target on the company's stock from $40 to $33. On Tuesday, MASI added 7.89% to its value to finish the day at $25.01.
-
Morgan Stanley Provides Color on Covidien
Wednesday, August 10, 2011 - 7:03am | 171Morgan Stanley provided color on Covidien (NYSE: COV). In a research report published today, the rating agency stressed its belief that the company's stock will rise relative to the industry in the next few months. In the report, Morgan Stanley states, “We believe the share price will rise...
-
China Medical Technologies Announces SFDA Approvals for its Prostate Cancer FISH Detection Kit and TOP2A FISH Detection Kit
Wednesday, August 10, 2011 - 7:01am | 101China Medical Technologies (Nasdaq: CMED) today announced that it has received approvals for its prostate cancer FISH detection kit and Topoisomerase 2-alpha ("TOP2A") FISH detection kit from the State Food and Drug Administration (the "SFDA") of the People's Republic of China. The Company has...
-
Piper Jaffray Lowers PT On Masimo To $36
Wednesday, August 10, 2011 - 6:15am | 27Piper Jaffray has lowered the price target on Masimo Corporation (NASDAQ: MASI) from $38 to $36 and maintains its Overweight rating.
-
Morgan Keegan Lowers PT On Masimo To $33
Wednesday, August 10, 2011 - 6:03am | 27Morgan Keegan has lowered the price target on Masimo Corporation (NASDAQ: MASI) from $40 to $33 and maintains its Outperform rating.
-
Masimo Announces Adoption of Stock Repurchase Program of up to 3M Shares
Tuesday, August 9, 2011 - 4:26pm | 126Masimo (NASDAQ: MASI) today announced that its Board of Directors has authorized the repurchase of up to 3 million shares of the company's common stock. The stock repurchase program may be carried out at the direction of the company through open market purchases, block trades, and in privately...
-
Meridian Bioscience Launches ImmunoCard C. difficile GDH Assay in Europe
Tuesday, August 9, 2011 - 3:47pm | 114Meridian Bioscience, Inc. (NASDAQ: VIVO) announced the launch of a new Clostridium difficile rapid test, ImmunoCard C. difficile GDH. This assay detects the common antigen, Glutamate dehydrogenase, produced by toxigenic and non-toxigenic strains of Clostridium difficile. Toxigenic strains of...
-
Market Losers
Tuesday, August 9, 2011 - 1:33pm | 182Sykes Enterprises (NASDAQ: SYKE) is trading down over 26% near $11.70 after reporting Q2 earnings. AOL (NYSE: AOL) is trading down over 24.60% near $11.35 after reporting Q2 earnings. Idenix Pharma (NASDAQ: IDIX) is trading down over 18% near $4.27 after reporting Q2 earnings. DTS (NASDAQ: DTSI) is...
-
Intraday Gainers
Tuesday, August 9, 2011 - 10:08am | 135MAKO Surgical (NASDAQ: MAKO) +22.61% after Piper Jaffray reiterates its Overweight rating and raises PT to $36. Northern Oil & Gas (NYSE: NOG) +21.43% on heavy volume. Scientific Games (NASDAQ: SGMS) +16.17% on upbeat earning reported this morning. Live Nation Entertainment (NYSE: LYV) +...
-
Morning Market Movers
Tuesday, August 9, 2011 - 9:51am | 120UTStarcom Holdings Corp (NASDAQ: UTSI) shares advanced 38.10% to $1.45 at 9:45 am. UTSI reported its Q2 net income at $0.07 per share, versus a loss of $0.07 per share, in the year-ago quarter. Anacor Pharmaceuticals Inc (NASDAQ: ANAC) climbed 34.77% to $5.00. ANAC is scheduled to report its Q2...
-
Oppenheimer Downgrading Stereotaxis
Tuesday, August 9, 2011 - 9:04am | 147Oppenheimer & Co. is downgrading shares of Stereotaxis, Inc. (NASDAQ: STXS) to Perform. In a note to clients, Oppenheimer & Co. writes, "We are lowering our rating on STXS to Perform from Outperform and removing our $5 price target. STXS reported a disappointing 2Q and rescinded guidance....